GlassScriptPhysician profile
Naresh A Dewan
NPI 1730294711
$4,630.73
in general payments reported to CMS, 2019-2025
35 companies · $1,300 in 2025
The $1,300 reported for 2025 was more than what 77% of Sleep Medicine (Internal Medicine) providers received nationally (typical 2025 total: $447).
See the full distribution for Sleep Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $489 · 2020: $114 · 2021: $85.65 · 2022: $154 · 2023: $1,148 · 2024: $1,340 · 2025: $1,300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,436 · Education: $353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,435.89 |
| Education | $352.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,177.09 | 2019-2025 | Fasenra, Breztri, Tezspire |
| Harmony Biosciences LLC | $586.19 | 2021-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $568.02 | 2019-2025 | |
| Zoll Respicardia, INC. | $286.75 | 2023-2024 | Remede System |
| Grifols USA, LLC | $228.37 | 2019-2025 | Prolastin-C Liquid |
| Merck Sharp & Dohme LLC | $157.40 | 2024-2025 | Winrevair |
| Inspire Medical Systems, INC. | $143.86 | 2025 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $137.17 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Regeneron Healthcare Solutions, INC. | $120.89 | 2021-2025 | Dupixent |
| Itamar Medical INC | $119.94 | 2023 | Watchpatone |
| Insmed, INC. | $115.89 | 2024-2025 | Arikayce, Brinsupri |
| United Therapeutics Corporation | $101.98 | 2020-2025 | |
| Amgen INC. | $93.54 | 2023-2025 | Tezspire |
| Genzyme Corporation | $80.18 | 2019-2025 | |
| Resmed Corp | $69.88 | 2023-2025 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avadel Cns Pharmaceuticals, LLC | $68.99 | 2024-2025 | Lumryz |
| Glaxosmithkline, LLC. | $64.41 | 2020-2024 | Nucala |
| Axsome Therapeutics, INC. | $60.65 | 2023-2025 | Sunosi |
| Takeda Pharmaceuticals U.S.A., INC. | $52.64 | 2023 | Glassia |
| Genentech USA, INC. | $41.68 | 2023 | Xolair |
| Actelion Pharmaceuticals US, INC. | $37.71 | 2022-2024 | Opsumit, Uptravi |
| Mylan Specialty L.P. | $37.13 | 2019-2024 | Yupelri |
| Pharming Healthcare, INC. | $31.25 | 2023 | Ruconest |
| Philips North America LLC | $29.12 | 2021-2024 | (Ak6) Vest Therapy |
| Janssen Pharmaceuticals, INC | $28.48 | 2023 | Xarelto |
| Mallinckrodt Hospital Products INC. | $27.21 | 2023 | Acthar |
| Ani Pharmaceuticals, INC. | $25.75 | 2024 | Purified Cortrophin Gel |
| Baxter Healthcare | $22.96 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Liquidia Technologies, INC. | $22.92 | 2025 | Yutrepia |
| Verona Pharma, INC. | $19.18 | 2025 | Ohtuvayre |
| Viatris Specialty LLC | $16.48 | 2025 | Yupelri |
| Gilead Sciences, INC. | $14.89 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.78 | 2023 | |
| Lilly USA, LLC | $13.79 | 2025 | Zepbound |
| Electromed, INC. | $13.56 | 2023 | Smartvest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Naresh Dewan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.